Vaccine compositions and methods for treatment of Mucormycosis and other fungal diseases

Details for Australian Patent Application No. 2010226320 (hide)

Owner Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Inventors Ibrahim, Ashraf S.; Spellberg, Brad J.; Fu, Yue; Edwards, John E.

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010226320

PCT Pub. Number WO2010/107500

Priority 61/161,614 19.03.09 US

Filing date 19 March 2010

Wipo publication date 23 September 2010

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/107500 Priority application(s): WO2010/107500

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010226326-Solid drug delivery apparatus, formulations and methods of use

2010226313-Modification of CXCR4 using engineered zinc finger proteins